Dr. Melissa K. Skupin, MD

Dr. Skupin practices at Family Allergy & Asthma in Louisville, Kentucky.

Dr. Skupin's NPI, 1003115502, was assigned on March 23, 2011. Dr. Skupin holds Kentucky license TP837.

Dr. Skupin's primary practice is Family Allergy & Asthma, at 9800 Shelbyville Rd, Louisville, KY 40223 in Jefferson County. The practice phone is (502) 429-8585.

Dr. Skupin's primary practice is Family Allergy & Asthma in Louisville, Kentucky. Dr. Skupin is also affiliated with Bethesda North Hospital. The medical group on file is Family Allergy & Asthma. Dmand AI also links Dr. Skupin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Skupin practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Skupin's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Skupin is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Skupin's licenses on file in 4 states: Kentucky, Illinois, Indiana and Ohio.

CMS data shows 5,291 Medicare services from Dr. Skupin across 13 procedure codes in 2024, for 152 Medicare patients. Medicare paid $40,805 for them. Every service was in an office.

CMS counts 152 Medicare patients who saw Dr. Skupin in 2024. The largest group is 65 to 74, with 92 patients. 73% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 0.78, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Skupin's median patient age at 47, with 63% women.

In 2024, Dr. Skupin wrote 1,055 Medicare Part D claims for 206 patients. 65% of them were for generic drugs. CMS names the drug for 971 of them, across 19 drugs with 11 or more claims each, at $385,428 in total drug cost. In 2023, CMS named 736 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Skupin for performance year 2024, reported as part of a group. Dr. Skupin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 401 general payments to Dr. Skupin from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,452.